Recent studies show that bevacizumab does not affect glioma stem cell-mediated vasculogenic mimicry38,39, suggesting that this mechanism may also contribute to anti-VEGF resistance in GBM. The gene discussed is VEGFA; the disease is central nervous system cancer.